Jubilant Therapeutics Inc to participate and present at upcoming Investor Conferences
BEDMINSTER, New Jersey – Nov 10, 2021 – Jubilant Therapeutics Inc., a private biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical needs in oncology and autoimmune diseases, today announced that its senior management team led by Syed Kazmi, Chief Executive Officer will participate in one-one-one meetings and present at the following investor conferences:
- Jefferies London Healthcare Conference
Date: Thursday, November 18th and Friday, November, 19th, 2021 (virtual)
- Piper Sandler Annual Healthcare Conference 2021
Date: Monday, November 29th, 2021 (virtual)